Hana Biosciences (NASADQ: HNAB)
will be announcing their Q4 and full year 2008 results during a conference call
on March 31, 2009 following the close of the financial markets. The Hana
Biosciences conference call will be held at 5:00 p.m. ET.
To
access the conference call in the U.S. and Canada dial (877) 407.8031 and for
International calls dial (201) 689.8031. A webcast will also be available at www.hanabiosciences.com.
A
replay of the conference call will be available for one week, in the U.S. and
Canada dial (877) 660.6853 and for International calls dial (201) 612.7415.
Account Number: #286 and Conference ID #317545. Access to an archived version
of the webcast will also be available on the Hana Biosciences website.
Hana
Biosciences, Inc. (NASDAQ: HNAB) is a South San Francisco, CA-based
biopharmaceutical company focused on acquiring, developing, and commercializing
innovative products to strengthen the foundation of cancer care. The company is
committed to creating value by building a best in-class team, accelerating the
development of lead product candidates, expanding its pipeline by being the
alliance partner of choice, and nurturing a unique company culture.
Click here for more Business News
About The Global Market Directory (TheGMD)
TheGMD provides an online global directory
listing featuring public companies, stock
brokers, brokerage firms and individuals. The GMD provides profiles for
Brokerage Firms, Stock Brokers and Individuals in addition to Public
Companies.
The GMD is a division of TransWorldNews, Inc.
Companies can utilize the TransWorldNews press release distribution services
and have all news releases attached to their GMD profile.
Create your profile on The Global Market
Directory.